看点view本周,2025医保、商保创新药目录调整过审名单公布,重点监控药品名单更新了;市场迎变局,28批次药品遭调查,大批常用药降价了;研发新进展,恒瑞拿下首个国产EZH2抑制剂,正大天晴2款1类新药首次获批临床;企业大新闻,扬子江、石药、齐鲁上榜民营500强,知名药企董事长摊上事,步长、通化东宝业绩大涨……医药行业一周大事件,精彩不容错过!米内一周TOP榜米内数据肝病中成药大跌!21个独家产品...
Source Link看点view本周,2025医保、商保创新药目录调整过审名单公布,重点监控药品名单更新了;市场迎变局,28批次药品遭调查,大批常用药降价了;研发新进展,恒瑞拿下首个国产EZH2抑制剂,正大天晴2款1类新药首次获批临床;企业大新闻,扬子江、石药、齐鲁上榜民营500强,知名药企董事长摊上事,步长、通化东宝业绩大涨……医药行业一周大事件,精彩不容错过!米内一周TOP榜米内数据肝病中成药大跌!21个独家产品...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.